Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
FRSH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.23
+900%
0.08
vs -0.01
Q4.23
+700%
0.08
vs 0.01
Q1.24
+233%
0.1
vs 0.03
Q2.24
+14%
0.08
vs 0.07
Q3.24
+38%
0.11
vs 0.08
Q4.24
+75%
0.14
vs 0.08
Q1.25
+80%
0.18
vs 0.1
Q2.25
+125%
0.18
vs 0.08
Q3.25
+19%
0.13
vs 0.11
Q4.25
-28%
0.1
vs 0.14
Sales Growth
YoY
Current
Estimates
Q3.23
+19%
153.6M vs 128.8M
Q4.23
+20%
160.1M vs 133.2M
Q1.24
+20%
165.1M vs 137.7M
Q2.24
+20%
174.1M vs 145.1M
Q3.24
+22%
186.6M vs 153.6M
Q4.24
+22%
194.6M vs 160.1M
Q1.25
+19%
196.3M vs 165.1M
Q2.25
+18%
204.7M vs 174.1M
Q3.25
+12%
208.9M vs 186.6M
Q4.25
+11%
216.6M vs 194.6M
Return on Equity
QoQ
Q1.23
-4%
-0.04
vs -0.05
Q2.23
-3%
-0.03
vs -0.04
Q3.23
-3%
-0.03
vs -0.03
Q4.23
-3%
-0.03
vs -0.03
Q1.24
-2%
-0.02
vs -0.03
Q2.24
-2%
-0.02
vs -0.02
Q3.24
-3%
-0.03
vs -0.02
Q4.24
-2%
-0.02
vs -0.03
Q1.25
0%
-0.00
vs -0.02
Q2.25
0%
-0.00
vs -0.00
Institutionnal Ownership
QoQ
Q4.22
158
158
vs 165
-4%
Q1.23
186
186
vs 158
18%
Q2.23
192
192
vs 186
3%
Q3.23
240
240
vs 192
25%
Q4.23
253
253
vs 240
5%
Q1.24
259
259
vs 253
2%
Q2.24
246
246
vs 259
-5%
Q3.24
258
258
vs 246
5%
Q4.24
289
289
vs 258
12%
Q1.25
311
311
vs 289
8%
Quote Panel
Key Metrics
globenewswire.com
8 hours ago
reuters.com
16 hours ago
youtube.com
17 hours ago
zacks.com
18 hours ago
fool.com
20 hours ago
seekingalpha.com
23 hours ago
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
25.00(86.99%)
Number of analyst
1
Last analyst upgrade/downgrade
Wells Fargo
initialisePrevious: Not converted
2024-10-16
Now: Equal-Weight
Oppenheimer
downgradePrevious: Outperform
2024-05-02
Now: Perform
Wolfe Research
upgradePrevious: Peer Perform
2024-02-20
Now: Outperform
Jefferies
upgradePrevious: Hold
2024-01-05
Now: Buy
Relative Strength
FRSH
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|